AML Contender Quizartinib Gains First Approval, In Japan

 
• By Ian Haydock

Japan grants first approval worldwide for Daiichi Sankyo's oral FLT3 inhibitor, marking progress for Japanese firm's global oncology ambitions.

Acute myeloid leukemia a 3d-Render
Japan Approval For Quizartinib In AML • Source: Shutterstock

More from Japan

More from Focus On Asia